Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) Ticker Search
Pro Search
Index Search
 QQQ: 62.94 -0.68%   SPY: 132.83 -0.38% FAQ | Sign Up Now | Login
Profile Portfolio  


  Track this Pro and follow their portfolio moves with tickerspy™ alerts  

Abingworth

  Performance       Similar Pro Portfolios       Community  
 
Today:
Week:
1-month:
All-time: 		+0.5%
-1.0%
+11.4%
+3.9% 		vs S&P 500:
vs S&P 500:
vs S&P 500:
vs S&P 500: 		+0.9%
+1.4%
+15.9%
-1.7%
 

Data since: Jan-1-2011
Current Portfolio: Q4 2011
     
Ardsley Advisor... +0.2%
Baker Bros. Adv... +1.4%
Private Capital... -0.5%
     
32 members Tracking
Share this Pro on Facebook
Share this Pro on Twitter
 
                     
     
 
Chart View
1 week
  
1 month
  
3 months
  
6 months
    
 
 

 
 
 
 
   
     
 
Portfolio Detail
 
  Standard View     Performance View    
Click a column to sort | Scroll over columns for more information
What are Alerts?
  
 Ticker Last Trade Today's Change Volume  % of
Daily		 Mkt Cap  Div Yield  % off
52wk lw		 % from
52wk hg		 Q4 2011 View as: Alerts Holdings Detail
 ALNY $10.29 -0.18 -1.72% 212,831 63% $543.3M - 75% -25% +26.3% $14.8M | 1.8M shares - No Change
 ALXA $0.41 +0.01 +1.23% 775,808 32% $48.0M - 8% -79% -50.6% $2.4M | 2.9M shares - No Change
 AMRN $11.24 +0.06 +0.54% 3,561,904 82% $1.5B - 88% -43% +50.1% $59.1M | 7.9M shares - No Change
 ASTX $1.63 -0.01 -0.61% 131,572 50% $152.6M - 8% -51% -13.8% $8.5M | 4.5M shares - No Change
 CLVS $19.15 +0.30 +1.59% 125,151 67% $421.8M - 67% -30% +35.9% $18.4M | 1.3M shares - New Holding
 CRME $0.49 -0.03 -5.77% 133,301 42% $31.7M - 10% -92% -81.4% $1.3M | 480.9K shares - No Change
 EXEL $4.92 -0.07 -1.40% 958,053 54% $740.8M - 25% -59% +3.9% $2.0M | 415.0K shares - No Change
 GEVA $38.43 -0.43 -1.11% 127,541 166% $825.3M - 283% -5% +44.3% $1.7M | 64.0K shares - No Change
 INCY $23.70 +0.95 +4.18% 2,094,895 128% $2.9B - 102% -2% +57.9% $12.5M | 830.4K shares - No Change
 ISIS $9.23 +0.04 +0.44% 500,555 82% $920.6M - 48% -1% +28.0% $1.9M | 267.6K shares - No Change
 MDCO $21.10 -0.04 -0.19% 234,852 68% $1.1B - 71% -8% +13.2% $2.0M | 107.0K shares - No Change
 NKTR $7.06 -0.11 -1.53% 638,110 63% $821.6M - 73% -30% +26.2% $3.7M | 663.9K shares - No Change
 NVAX $1.27 0.00 0.00% 2,545,756 300% $155.0M - 12% -49% +0.8% $1.9M | 1.5M shares - No Change
 OGXI $12.51 -0.14 -1.11% 42,939 46% $183.9M - 45% -34% +6.6% $7.1M | 603.7K shares - No Change
 ZGNX $1.82 -0.07 -3.70% 147,008 90% $123.5M - 39% -64% -18.0% $5.2M | 2.3M shares - No Change
Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Discuss Abingworth's portfolio
 
Latest Portfolio Notes & Links
 
View: Headlines   |   Message Board   |   Portfolio Notes  
 
 
Astex Pharmaceuticals to Present at ASCO Annual Meeting
ASTX  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 16, 06:00AM from (www.globenewswire.com)
DUBLIN, Calif., May 16, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Zogenix Reports First Quarter 2012 Financial Results
ZGNX  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 14, 04:00PM from (www.globenewswire.com)

SAN DIEGO, May 14, 2012 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
NASDAQ Changes Up Biotech Index Members & Weightings
CLDX  CBRX  CERS  BPAX  CRME  RPTP  DRRX  INFI  IBB  FOLD  JAZZ  OMER  CBPO  OREX  TSRX  PCRX  BBH  XBI  
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 14, 07:59AM from (247wallst.com)
Index changes are generally speaking a fairly routine event. They can also create underlying moves in the companies added  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Cardiome Reports First Quarter Results
CRME  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 11, 04:00PM from (www.globenewswire.com)
VANCOUVER, British Columbia, May 11, 2012 (GLOBE NEWSWIRE) -- Cardiome Pharma Corp. (Nasdaq:CRME) (TSX:COM) today reported  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Cardiome to Release First Quarter 2012 Financial Results
CRME  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 10, 05:06PM from (www.globenewswire.com)
VANCOUVER, British Columbia, May 10, 2012 (GLOBE NEWSWIRE) -- Cardiome Pharma Corp. (Nasdaq:CRME) (TSX:COM) today announced  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Alexza Reports 2012 First Quarter Financial Results and Provides Business Update
ALXA  
Posted by PR Newswire ( track newsfeed | ignore newsfeed ) - May 10, 04:05PM

MOUNTAIN VIEW, Calif., May 10, 2012 /PRNewswire/ -- Alexza  more ...
Flag Post a comment

Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Taking An Early Look at 2012 ASCO Biotech/Cancer Stocks
LLY  BVTI  CLDX  IMGN  ARIA  NKTR  EXEL  PCYC  GNBT  SGEN  ARRY  DNDN  GHDX  ABPI  CYTR  GALE  NLNK  
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 10, 12:02PM from (247wallst.com)
It is now getting close to the middle of May, and that means one thing for biotech investors. The king of biotech and pharma  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
NOVAVAX Launches Additional Phase I Clinical Trial of A/H5N1 Influenza Vaccine Candidate
NVAX  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 09, 08:00AM from (www.globenewswire.com)
ROCKVILLE, Md., May 9, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today that it has begun enrollment  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Biotechs Bucking The Dendreon Trap & Curse
AMGN  SVNT  VRTX  VVUS  ARNA  DNDN  ALNY  
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 08, 01:15PM from (247wallst.com)
When we issued our earnings previews for the week ahead, it looked as though Dendreon Corporation (NASDAQ: DNDN) had a chance  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Isis Reports Financial Results and Highlights for First Quarter 2012
ISIS  
Posted by PR Newswire ( track newsfeed | ignore newsfeed ) - May 08, 07:00AM

CARLSBAD, Calif., May 8, 2012 /PRNewswire/ -- Isis Pharmaceuticals,  more ...
Flag Post a comment

Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Cardiome Receives Notification From NASDAQ
CRME  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 04, 06:01PM from (www.globenewswire.com)
VANCOUVER, British Columbia, May 4, 2012 (GLOBE NEWSWIRE) -- Cardiome Pharma Corp. (Nasdaq:CRME) (TSX:COM) ("the Company")  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Alexza Says It Can Resolve FDA Roadblock to Antipsychotic
BMY  LLY  PFE  LAZ  ALXA  
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 04, 10:12AM from (www.bloomberg.com)
Alexza Pharmaceuticals Inc. (ALXA) said it can resolve the concerns about its drug-making facility that led regulators to  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
NOVAVAX Reports First Quarter 2012 Financial Results
NVAX  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 04, 08:00AM from (www.globenewswire.com)
ROCKVILLE, Md., May 4, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced its financial results for the  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Zogenix Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
ZGNX  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 03, 07:30AM from (www.globenewswire.com)
SAN DIEGO, May 3, 2012 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
NKTR  
Posted by PR Newswire ( track newsfeed | ignore newsfeed ) - May 02, 04:15PM

SAN FRANCISCO, May 2, 2012 /PRNewswire/ -- Nektar Therapeutics  more ...
Flag Post a comment

Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
NOVAVAX Launches Phase I Clinical Trial of A/H5N1 Influenza Vaccine Candidate
NVAX  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 02, 08:00AM from (www.globenewswire.com)
ROCKVILLE, Md., May 2, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today that it has begun enrollment  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Amarin to Report First Quarter 2012 Financial Results and Host Conference Call on May 8, 2012
AMRN  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 01, 04:10PM from (www.globenewswire.com)
BEDMINSTER, N.J. and DUBLIN, Ireland, May 1, 2012 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN), a late-stage  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Astex Pharmaceuticals Reports 2012 First Quarter Financial Results
ASTX  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - April 30, 04:00PM from (www.globenewswire.com)

DUBLIN, Calif., April 30, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), today reported financial  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
NOVAVAX to Report First Quarter 2012 Financial Results on May 4, 2012
NVAX  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - April 26, 08:00AM from (www.globenewswire.com)
ROCKVILLE, Md., April 26, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that it will report its 2012  more ...
Flag Post a comment
Please flag this item as:
Close [X]
• Spam
• Duplicate post
• Inappropriate content
• Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6 7 8 9 ... 42



Home | About | Register | My tickerspy | Logout Web site design by LightMix
© 2007-2012 Indie Research, LLC. All rights reserved.  

 

---
The information herein is provided by various sources including individual contributors not associated with Indie Research and is not guaranteed by us and does not purport to be a complete or error-free statement or summary of the available data. As such, we do not warrant, endorse or guarantee the completeness, accuracy, integrity or timelines of the information. You must evaluate, and bear all risks associated with, the use of any information provided hereunder, including any reliance on the accuracy, completeness, safety or usefulness of such information. This information is not intended to be used as the primary basis of investment decisions. It should not be construed as financial or other advice or as an offer to sell or the solicitation of an offer to buy any security in any state where such an offer or solicitation would be illegal. Any information expressed herein on this date is subject to change without notice. Any opinions or assertions contained in this information do not represent the opinions or beliefs of Indie Research, LCC or one or more of its employees, may have a position in any of the securities discussed herein. Use of the tickerspy.com, signifies your agreement to the Terms of Use.

Institutional Holdings Disclaimer

Pro portfolios track the top 15 quarterly holdings of more than 1,400 institutions. Comments in Pro portfolios show the institution's change in shares held for each company quarter over quarter.

Pro portfolio performance is based on institutions' top 15 holdings as disclosed in quarter-end filings with the SEC. Pro performance does not take into account additional holdings beyond the top 15 nor does it include positions that are not required to be disclosed by the SEC. As such, Pro portfolio performance should be considered an approximation and not a precise record of how an institution has performed over time.

tickerspy is not affiliated with any of the Pro investors profiled on our web site. The performance data and graph are estimates and do not represent an advertisement or endorsement by either tickerspy or the Pro investors.

THE INFORMATION PROVIDED TO YOU HEREUNDER IS PROVIDED "AS IS" AND TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, INDIE RESEARCH, LLC AND IT LICENSORS, BUSINESS ASSOCIATES AND SUPPLIERS DISCLAIM ALL WARRANTIES WITH RESPECT TO THE SAME, EXPRESS, IMPLIED AND STATUTORY, INCLUDING WITHOUT LIMITATION ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, ACCURACY, COMPLETENESS AND NON-INFRINGEMENT. TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, NEITHER INDIE RESEARCH, LLC NOR ITS OFFICERS, MEMBERS, DIRECTORS, PARTNERS, AFFILIATES, BUSINESS ASSOCIATES, LICNESORS OR SUPPLIERS WILL BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL OR PUNITIVE DAMAGES, INCLUDING WITHOUT LIMITATION DAMAGAES FOR LOST PROFITS OR REVENUES, GOODWILL, WORK STOPPAGE, SECURITY BREACHES, VIRUSES, COMPUTER FAILURE OR MALFUNCTION, USE, DATA OR OTHER INTANGIBLE LOSSES OR COMMERCIAL DAMAGES, EVEN IF ANY OF SUCH PARTIES ADVISED OF THE POSSIBILITY OF SUCH LOSSES, ARISING UNDER OR IN CONNECTION WITH THE INFORMATION PROVIDED HEREIN OR ANY OTHER SUBJECT MATTER HEREOF.


Market Data Powered by Interactive Data
Terms and Conditions

Close [X]  
Post a description about this portfolio.
(150 character limit)

Click to close X

Use portfolios to track tickers you're interested in. News related to your tickers will appear below the portfolio. Tickers in your portfolios will generate Alerts on your tickerspy Alerts page.

The Recent Tickers portfolio saves the tickers you've recently viewed on the site.
Click to close X

By matching similar portfolios, tickerspy helps members find institutional and individual investors with strategies similar to their own.
Click to close X

Portfolio performance for tickerspy member portfolios is calculated by equally weighting all of the stocks held in the portfolio.
Click to close X

Performance View offers a snapshot of how individual portfolio positions have performed since being added (or shorted) as well as a look at the individual stocks' performance over various time periods. In the case of "shorts," a decline in price will result in a positive gain.

Portfolio History offers a view of all current and past holdings in a portfolio.
Click to close X

Institutional Holdings Disclaimer

Pro portfolios track the top 15 quarterly holdings of more than 1,400 institutions. Comments in Pro portfolios show the institution's change in shares held for each company quarter over quarter.

Pro portfolio performance is based on institutions' top 15 holdings as disclosed in quarter-end filings with the SEC. Pro performance does not take into account additional holdings beyond the top 15 nor does it include positions that are not required to be disclosed by the SEC. As such, Pro portfolio performance should be considered an approximation and not a precise record of how an institution has performed over time.

tickerspy is not affiliated with any of the Pro investors profiled on our web site. The performance data and graph are estimates and do not represent an advertisement or endorsement by either tickerspy or the Pro investors.
Click to close X

To calculate "all-time" Pro performance, we combine all of the quarterly holdings reports for that Pro investor. The initial date used is the start date of the first quarterly holdings report we have in our database. Start dates vary based on the first quarterly holdings report we have for each Pro. Please see our Institutional Holdings Disclaimer (located at the bottom of this page) for more on how we calculate Pro portfolio performance estimates. tickerspy is not affiliated with any of Pro investors profiled on our web site.
Click to close X

Your primary portfolio will appear in other member’s Tracking Hubs when they track your performance. Your primary portfolio is also used in our Ideas & Research section, where your portfolio is compared with the portfolios of other members, and elsewhere on the site where other portfolio comparisons are made.

Note: Primary portfolios must contain at least five stocks of greater than $1 per share. If you have elected to make your primary portfolio private or if your portfolio is not eligible to be primary, it will not appear in the Ideas & Research section or on the front page.
Click to close X

Primary portfolio

Click to close X
Click the Alerts links in your portfolio to see news from the last 36 hours as well as data alerts displaying unusual price and volume action. You will also see Alerts related to the activity of other tickerspy members. To see more Alerts, visit your customized Alerts page. And for more Alerts info, visit our Alerts FAQ.
Click to close X
The Recent Tickers portfolio saves the tickers you've recently viewed on the site.